Simplify Logo
Clorox

Clorox

Manufactures and markets consumer cleaning products

Microbiology Lab Associate - 3rd Shift

Full-Time
$25.39/hr

+ $1.20 shift differential

Entry, Junior
Associate's, Associate of Science (AS)
Morrisville, NC, USA
In Person

About the job

Requirements
  • An Associate of Arts or Associate of Science degree in a related field, or two years of progressively responsible related work experience in the manufacturing industry, preferably pharmaceutical, food, or cosmetics.
  • Proficient computer skills in Word and Excel, with the ability to learn additional programs.
  • Demonstrated analytical reasoning ability.
  • Demonstrated ability to operate and troubleshoot testing equipment.
  • Understanding of microbiology processes, plating, and methods.
  • Exceptional attention to detail and organizational skills.
  • Ability to lift up to 40 pounds.
  • Ability to stand and walk for several hours per day.
  • Ability to stoop, kneel, and squat periodically while inspecting or sampling.
  • Ability to work in a heavy manufacturing environment with loud noise and hot and cold temperatures.
  • Experience and knowledge of applicable regulations.
  • Ability to follow company safety and good manufacturing practice regulations and procedures.
  • Ability to work effectively across all organizational levels, from the shop floor to upper management.
  • Ability to work independently and within a team environment.
Responsibilities
  • Perform microbial testing, visual inspections, and release activities for finished goods, bulk materials, and raw materials.
  • Provide backup testing to support laboratory operations and business needs.
  • Operate and troubleshoot laboratory equipment.
  • Perform microbial testing in accordance with USP <61> microbial enumeration and USP <62> specified microorganisms using rapid microbial testing methods.
  • Accurately document testing information and results in real time.
  • Support bulk and raw material testing and perform release activities as needed, including sensory, pH, viscosity, and penetration testing.
  • Review test data and perform release transactions in SAP.
  • Support production lines by answering quality-related questions and ensuring required quality standards are met.
  • Document and support investigations of quality issues, including out-of-specification results, nonconformance reports, and deviations.
  • Prepare and sterility test media for raw material testing.
  • Review Chain of Custody and Line Clearance forms before distributing finished-goods samples for testing.
  • Assist with laboratory cleaning processes and communicate testing-supply inventory needs.
  • Create, revise, and review standard operating procedures, job aids, and One Point Lessons as needed.
  • Complete annual current Good Manufacturing Practice, safety, and sustainability training and quarterly general and safety improvements.
  • Operate microbiology laboratory equipment, including the Neogen Soleris and autoclave.
  • Operate pH meters, viscometers, penetrometers, and total organic carbon analyzers.
  • Calibrate pH meters and scales.
  • Provide support to the Microbiology Technician and backup to the quality laboratory.
  • Follow safety, Good Laboratory Practice, Good Documentation Practice, and Good Manufacturing Practice regulations and procedures.
  • Complete training related to safety, Good Manufacturing Practice, sustainability, and environmental requirements.
  • Use continuous-improvement tools.
  • Ensure expired material is labeled appropriately.
  • Provide backup to the raw-material sampler.
  • Contribute to quality projects as assigned.
Desired Qualifications
  • Experience using SAP and Outlook.
  • Experience in pharmaceutical, food, or cosmetics manufacturing.

About the company

Clorox makes and sells cleaning supplies, household products, and some food products through a portfolio of well-known brands. Its products are offered to both consumers and professional users and distributed via mass merchandisers, grocery stores, and online channels around the world. How the products work: cleaning and disinfecting products are used to sanitize and maintain surfaces and homes, while household items and food-related products support everyday routines. How it stands out: instead of relying on a single product or category, Clorox combines a broad brand lineup with sales across multiple markets and customer channels, giving it broad reach and stability. Its goal is to provide trusted brands that help people keep spaces clean and safe while meeting the needs of both individual consumers and professional customers.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Oakland, California

Founded

1913

Get referred to Clorox

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • GOJO closed in April 2026, adding Purell and B2B hygiene depth.
  • Clorox FY27 guides 13%-14% sales growth, with 3.5%-4.5% organic growth.
  • New products like Clorox PURE and Screen+ Sanitizing Wipes broaden shelf and channel wins.

What critics are saying

  • CEO Linda Rendle plans to exit after a successor is named, unsettling execution.
  • Clorox seeks $380 million from Cognizant over the 2023 cyberattack, exposing lingering weakness.
  • FY26 adjusted EPS fell about 23%; another cybershock or integration slip worsens the franchise.

What makes Clorox unique

  • Purell acquisition made health and hygiene more than half of net sales in 2026.
  • Clorox owns 30 brands, including Brita, Glad, Hidden Valley, Pine-Sol, and Burt's Bees.
  • TikTok Shop experiments like Pine-Sol give Clorox faster consumer feedback and relevance.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Family Planning Benefits

Fertility Treatment Support

Wellness Program

Mental Health Support

Company News

Ticker Report
Aug 21st, 2026
OVERSEA CHINESE BANKING Corp Ltd Makes New $7.06 Million Investment in The Clorox Company $CLX

OVERSEA CHINESE BANKING Corp Ltd acquired a new position in shares of The Clorox Company (NYSE:CLX – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 73,976 shares of the company’s stock, valued at approximately $7,060,000. OVERSEA CHINESE BANKING Corp […]

Yahoo Finance
Aug 12th, 2026
Clorox beats revenue estimates despite 2% decline, misses guidance with $5.85 EPS outlook

Clorox's second quarter revenue beat analyst expectations at $1.95 billion, despite a 2% year-on-year decline. CEO Linda Rendle attributed performance to improvements in product quality, brand investments, and promotional execution. The company reported adjusted EPS of $1.66, narrowly beating estimates. However, operating margin fell to 12.9% from 21% in the prior year period. Clorox guided adjusted EPS of $5.85 for financial year 2027, missing analyst expectations by 1.7%. Management highlighted ongoing productivity initiatives and early integration of the GOJO acquisition. During the earnings call, analysts questioned market share expectations, promotional activity levels, and dividend policy. The company expects sequential share improvement, particularly in Home Care and Professional segments, while acknowledging challenges in Litter and Grilling categories.

PR Newswire
Aug 3rd, 2026
Clorox Q4 sales drop 2% to $1.95B, forecasts up to 14% FY27 growth after GOJO acquisition

Clorox reported fourth-quarter fiscal 2026 results ending 30 June, with net sales decreasing 2% to $1.95 billion. The company completed its acquisition of GOJO Industries in April 2026, which added approximately 10 percentage points to sales. Organic sales fell 13%, primarily due to lapping incremental shipments related to an ERP transition. Diluted earnings per share dropped 50% to $1.34 from $2.68 year-over-year. Gross margin decreased 520 basis points to 41.3%. For fiscal 2027, Clorox expects net sales growth of 13% to 14%, including 9.5 points from the GOJO acquisition. Organic sales are projected to increase 3.5% to 4.5%. Adjusted EPS is forecast between $5.70 and $6.00, representing growth of 3% to 8%. The company completed its five-year US ERP implementation during the fiscal year.

Yahoo Finance
Jul 29th, 2026
Clorox faces 43% earnings drop and bearish analyst outlook ahead of August results

Clorox faces a challenging outlook ahead of its June 2026 quarter earnings call on 3 August. Analysts expect quarterly earnings of $1.64 per share and revenues of $1.91 billion, representing year-over-year declines. The company's weaker forecast is accompanied by bearish analyst sentiment, including a negative Earnings ESP and lower independent ranking. These factors highlight concerns about Clorox's near-term earnings trajectory. In April, Clorox cut its fiscal 2026 guidance, projecting net sales to fall approximately 6% and diluted EPS between $4.78 and $4.98. The company attributes the weakness to demand pressures and cost headwinds, despite the GOJO acquisition and VMS divestiture. Success will depend on whether its ERP rollout and late fiscal 2026 product launches can offset current pressures from value-seeking consumers and aggressive competition.

Yahoo Finance
Jul 20th, 2026
Clorox returned $3.8B to shareholders as stock fell 37% over five years

Clorox has returned $3.8 billion to shareholders over the past five years through dividends and buybacks, representing 33% of its current market capitalisation. Despite this substantial payout, the stock has fallen 37% during that period, whilst the S&P 500 gained 82%. The consumer staples company generates $6.76 billion in annual revenue from household brands. Management attributes the stock's underperformance to slower-than-expected business improvements and execution challenges. Key initiatives, including the Fresh Step litter brand reinvention, have faced difficulties. Clorox's capital return programme significantly exceeds the S&P 500 median of 16.6% of market value, reflecting a mature business generating excess cash. However, operational struggles have left the stock trading around $96.32, approximately 40% below its two-year high.